Randomised controlled trial of Meropenem versus Piperacillin-Tazobactam for definitive treatment of bloodstream infections due to Ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (2013–2014)

Grant type:
International Society of Chemotherapy
Funded by:
International Society of Chemotherapy